Table 1 Baseline characteristics of the studied patients on admission.

From: Fluid restriction management in the treatment of COVID-19: a single-center observational study

 

Group 1 (N = 48)

Group 2 (N = 43)

Group 3 (N = 25)

Age, years

58 (47–70)

65 (53–71.5)

56 (51–62)

Male, n (%)

40 (83.3)

31 (72.1)

19 (76.0)

Transfer, n (%)

26 (54.2)

33 (76.7)

20 (80)

Height, cm

171 (163–178)

167 (160–170)

166 (160–171)

Weight, kg

76.4 (66.25–90.5)

70 (59–82.6)

83.4 (73.2–100)

BMI, kg/m2

26 (23.1–30.2)

27.1 (22.7–31.1)

31.5 (27.1–33.1)

Lactate, mmol/L

1.5 (1.15–1.85)

1.45 (1.2–1.95)

1.5 (1.1–1.9)

WBC, /103μL

6.3 (4.9–8.95)

7.4 (4.7–10.7)

8.5 (5.8–12.7)

Hb, g/dL

14.4 (13–15.3)

13.4 (12.75–14.4)

14.1 (12.9–14.9)

Ht, %

41.4 (38.3–44.2)

39.5 (36.8–42.1)

40.8 (37.9–42.6)

Plt, /103μL

199 (168–249)

217 (154–253)

208 (171–257)

Neu, %

82.1 (74.2–87.4)

87.5 (83.1–91.6)

87.7 (82.5–91.5)

Lym, %

12.6 (8.6–20)

8.3 (4.4–13.7)

9.3 (5.7–13.2)

Mo, %

4.5 (3.1–6.2)

2.9 (2.2–5)

3 (2–5.2)

Eo, %

0.1 (0–0.3)

0 (0–0)

0 (0–0)

Ba, %

0.1 (0.1–0.2)

0.1 (0.1–0.2)

0.2 (0.1–0.2)

Glucose, mg/dL

142 (117–164.5)

179 (144.5–220.5)

181 (131–209)

TP, g/dL

6.5 (6–6.9)

6.2 (5.9–6.7)

6.2 (5.9–6.7)

Albumin, g/dL

3.2 (2.9–3.6)

2.8 (2.7–2.9)

2.9 (2.6–3.2)

BUN, mg/dL

16 (13–20)

20 (17–31)

22 (15–29)

Creatinine, mg/dL

0.8 (0.7–0.95)

0.8 (0.6–1.1)

0.8 (0.6–1.3)

T-bil, mg/dL

0.6 (0.5–0.8)

0.6 (0.45–0.8)

0.7 (0.4–1.2)

CRP, mg/dL

4.39 (2.5–11.75)

7.99 (3.45–15.6)

13.09 (4.64–17.85)

CK, /UL

99 (57–163)

103 (53–241)

334 (102–452)

HbA1c, %

6.5 (6–7.7)

6.6 (6.1–7.6)

6.7 (6.4–7.3)

Mg, mg/dL

2.2 (2–2.3)

2.2 (2–2.35)

2.2 (1.9–2.3)

IP, mg/dL

3 (2.6–3.5)

3.6 (3–4.35)

3.4 (2.6–4.2)

Ferritin, ng/mL

762.3 (392.1–1400.2)

1156.2 (607.6–1526.7)

1052.7 (598.7–1666.8)

PT-INR

1.02 (0.97–1.18)

1.06 (1.02–1.14)

1.06 (1.01–1.13)

APTT, s

30.8 (28.9–34.7)

34.8 (30.1–44.1)

33 (28.7–44.5)

Fibrinogen, mg/dL

543 (468–606)

579 (478–678)

602 (504–686)

d-Dimer, μg/mL

2.1 (1.8–2.9)

2.7 (2.1–3.9)

3 (2.3–6.3)

  1. BMI body mass index, WBC white blood cell, Hb hemoglobin, Ht hematocrit, Plt platelet, Neu neutrophil, Lym lymphocyte, Mo monocyte, Eo eosinophil, Ba basophil, TP total protein, BUN blood urea nitrogen, T-bil total bilirubin, CRP C-reactive protein, CK creatinine kinase, Mg magnesium, IP inorganic phosphorus, PT-INR prothrombin time-international normalized ratio, APTT activated partial thromboplastin time.